Structure–activity relationships of synthetic progestins in a yeast-based in vitro androgen bioassay

  title={Structure–activity relationships of synthetic progestins in a yeast-based in vitro androgen bioassay},
  author={LS McRobb and David Handelsman and Rymantas Kazlauskas and Scott Wilkinson and Malcolm D. McLeod and Alison K. Heather},
  journal={The Journal of Steroid Biochemistry and Molecular Biology},

Figures and Tables from this paper

Evaluation of androgenic activity of nutraceutical-derived steroids using mammalian and yeast in vitro androgen bioassays.
It is indicated that steroids extracted from nutraceuticals can be converted in vitro into more or less potent androgens in mammalian but not in yeast cells and that mammalian cell bioassays may have an added benefit in screening for proandrogens but sacrifice specificity for sensitivity in quantitation.
Non-targeted detection of designer androgens: Underestimated role of in vitro bioassays.
It is important to continue to develop new and effective detection approaches to prevent misuse of designer androgens and in vitro bioassays represent a potential solution to non-targeted detection strategies.
The use of bioassays to detect designer androgens in sports supplements
The overall hypothesis of this thesis was that designer steroids contained within sports supplements are potent androgens, and the Australian sports supplement market was screened for undeclared androgenic substances.
Structure-Activity Relationships
  • M. Lakshmanan
  • Biology, Chemistry
    Introduction to Basics of Pharmacology and Toxicology
  • 2019
In-depth analysis of the structure of the drug and its subsequent modification yield drugs with high affinity and increased receptor specificity with an improved pharmacokinetic profile. Modification
In Vitro Androgen Bioassays as a Detection Method for Designer Androgens
In vitro androgen bioassays can detect designer and proandrogens as these assays are not reliant on knowing the chemical structure but instead are based on androgen receptor activation.
The challenge presented by progestins in ecotoxicological research: a critical review.
The ability to impair female reproduction at very low concentrations makes the progestins arguably the most important pharmaceutical group of concern after ethinylestradiol.
Unravelling androgens in sport: altrenogest shows strong activation of the androgen receptor in a mammalian cell bioassay.
It is shown unequivocally that altrenogest, a progestogen used widely in female racehorses, acts as a strong androgen in a mammalian cell bioassay.
A novel steroidal antiandrogen targeting wild type and mutant androgen receptors.


124. Tetrahydrogestrinone (THG) is a potent androgen and progestin
It is concluded that Tetrahydrogestrinone is a potent androgen and progestin, which shows similar potency to the comparator androgens, nandrolone, norbolethone, 5α-norboleth one and trenbolone.
New progestagens for contraceptive use.
Several new progestins, including dienogest (DNG), drospirenone (DRSP), Nestorone (NES), nomegestrol acetate (NOMAc) and trimegestone (TMG) have been synthesized in the last two decades, designed to have no androgenic or estrogenic actions and to be closer to the physiological hormone P.
Specific Recognition of Androgens by Their Nuclear Receptor
A homology model of the ligand-binding domain (LBD) of the human androgen receptor (hAR) was constructed based on the progesterone receptor LBD crystal structure, which suggests new directions for drug design.
Issues arising when interpreting results from an in vitro assay for estrogenic activity.
A previously described estrogen-inducible recombinant yeast strain is used to investigate a number of issues that could potentially lead to the mislabeling of chemicals as endocrine disruptors, and considerable care must be applied when interpreting results derived from any single assay.
Evaluation of chemicals with endocrine modulating activity in a yeast-based steroid hormone receptor gene transcription assay.
The utility of using yeast-based receptor assays for detecting chemical interaction with steroid receptors is demonstrated and these assays should serve as a useful component of an in vitro-in vivo strategy to assess the effects of chemicals on endocrine function.
Another designer steroid: discovery, synthesis, and detection of 'madol' in urine.
A baboon administration study showed that madol and a metabolite are excreted in urine, and a method for rapid screening of urine samples by gas chromatography/mass spectrometry of trimethylsilylated madol was developed.
A yeast estrogen screen for examining the relative exposure of cells to natural and xenoestrogens.
The utility of the yeast estrogen screen (YES) for identifying and characterizing environmental estrogens and selective binding of 17 beta-estradiol by proteins in serum indicates that certain xenoestrogens may exert greater estrogenicity than originally predicted.
Pharmacology, Pharmacokinetics, and Metabolism of Acetothiolutamide, a Novel Nonsteroidal Agonist for the Androgen Receptor
The high plasma clearance of acetothiolutamide, due to its extensive hepatic metabolism, likely contributed to its lack of androgenic activity in vivo.
Classification and pharmacology of progestins.
Steroid hormone receptors and pharmacology.